CAMP4 Therapeutics Corporation (CAMP) Insider Trading Activity
NASDAQ$2.02
Market Cap
$40.73M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
481 of 878
Rank in Industry
281 of 506
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
CAMP Insider Trading Activity
CAMP Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $7,176 | 1 | 100 |
Related Transactions
| Cohenour Jason | director | 0 | $0 | 1 | $7,176 | $-7,176 |
About CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Insider Activity of CAMP4 Therapeutics Corporation
Over the last 12 months, insiders at CAMP4 Therapeutics Corporation have bought $0 and sold $7,176 worth of CAMP4 Therapeutics Corporation stock.
On average, over the past 5 years, insiders at CAMP4 Therapeutics Corporation have bought $3.4M and sold $7,176 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $112,970 was made by Cummins Wes (director) on 2023‑01‑27.
List of Insider Buy and Sell Transactions, CAMP4 Therapeutics Corporation
| 2024-06-05 | Sale | Cohenour Jason | director | 8,640 0.5356% | $0.83 | $7,176 | +494.40% | |
| 2023-01-27 | Cummins Wes | director | 25,000 0.069% | $4.52 | $112,970 | -80.57% | ||
| 2023-01-03 | Cummins Wes | director | 20,000 0.0546% | $4.43 | $88,610 | -77.06% | ||
| 2022-12-30 | Cummins Wes | director | 30,000 0.0831% | $4.48 | $134,442 | -76.56% | ||
| 2022-12-29 | Cummins Wes | director | 25,000 0.0661% | $4.35 | $108,655 | -76.70% | ||
| 2022-12-28 | Cummins Wes | director | 25,000 0.0678% | $3.95 | $98,790 | -73.70% | ||
| 2022-12-27 | Cummins Wes | director | 40,000 0.1117% | $4.00 | $160,188 | -73.30% | ||
| 2022-12-23 | Cummins Wes | director | 25,000 0.0694% | $4.17 | $104,340 | -73.92% | ||
| 2022-11-10 | Cummins Wes | director | 43,600 0.1195% | $3.37 | $146,880 | -41.12% | ||
| 2022-11-09 | Cummins Wes | director | 63,500 0.1727% | $3.04 | $192,786 | -34.53% | ||
| 2022-10-14 | Cummins Wes | director | 75,000 0.2062% | $3.25 | $243,593 | -9.23% | ||
| 2022-10-14 | GARDNER JEFFERY R | President & CEO | 2,000 0.0057% | $3.36 | $6,719 | -9.23% | ||
| 2022-10-13 | Cummins Wes | director | 75,000 0.2065% | $3.26 | $244,710 | -6.44% | ||
| 2022-10-12 | Cummins Wes | director | 60,000 0.1659% | $3.38 | $202,680 | -8.63% | ||
| 2022-10-11 | Cummins Wes | director | 50,000 0.1374% | $3.56 | $177,900 | -13.48% | ||
| 2022-10-10 | Cummins Wes | director | 50,000 0.1387% | $3.95 | $197,705 | -21.17% | ||
| 2022-10-10 | GARDNER JEFFERY R | President & CEO | 2,000 0.0055% | $3.95 | $7,898 | -21.17% | ||
| 2022-10-07 | Cummins Wes | director | 100,000 0.2767% | $4.04 | $404,430 | -22.26% | ||
| 2022-09-30 | Cummins Wes | director | 84,300 0.2356% | $3.90 | $328,854 | -16.80% | ||
| 2022-09-28 | Cummins Wes | 102,500 0.2822% | $4.39 | $450,334 | -26.88% |
Total: 350
*Gray background shows transactions not older than one year
Insider Historical Profitability
20.49%
| Cohenour Jason | director | 0 0% | $0 | 0 | 1 | |
| Cummins Wes | director | 3424059 16.9835% | $6.92M | 21 | 0 | <0.0001% |
| B. Riley Asset Management, LLC | 2229159 11.0567% | $4.5M | 6 | 0 | <0.0001% | |
| Burdiek Michael J | President & CEO | 615020 3.0505% | $1.24M | 11 | 35 | +72.01% |
| GARDNER JEFFERY R | President & CEO | 487971 2.4204% | $985,701.42 | 21 | 0 | <0.0001% |
| GOLD RICHARD B | director | 385439 1.9118% | $778,586.78 | 47 | 12 | +40.79% |
| VITELLE RICHARD K | Executive VP & CFO | 249211 1.2361% | $503,406.22 | 16 | 46 | +28.31% |
| PERNA FRANK JR | director | 224722 1.1146% | $453,938.44 | 28 | 17 | +22.36% |
| Sarkissian Garo Sarkis | SVP Corporate Development | 178876 0.8872% | $361,329.52 | 5 | 23 | <0.0001% |
| BINDER KURTIS JOSEPH | Chief Financial Officer | 177718 0.8815% | $358,990.36 | 1 | 0 | <0.0001% |
| WOLFE LARRY J | director | 171275 0.8495% | $345,975.50 | 11 | 2 | +15.21% |
| STURM FRED M | President & CEO | 160000 0.7936% | $323,200.00 | 4 | 2 | +1.68% |
| PARDUN THOMAS E | director | 119345 0.592% | $241,076.90 | 16 | 2 | +44.73% |
| Johnson Amal M | director | 97049 0.4814% | $196,038.98 | 4 | 0 | +25.27% |
| MOYER ALBERT J | director | 88676 0.4398% | $179,125.52 | 1 | 2 | +8.97% |
| Alexy Kimberly | director | 47729 0.2367% | $96,412.58 | 2 | 6 | +115.36% |
| HUTCHINS PATRICK | President, Satellite Division | 39750 0.1972% | $80,295.00 | 3 | 0 | <0.0001% |
| HAUSMAN ARTHUR H | director | 5210 0.0258% | $10,524.20 | 0 | 2 | |
| OUSLEY JAMES E | director | 5159 0.0256% | $10,421.18 | 0 | 3 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
CAMP4 Therapeutics Corporation (CAMP) | $12,784,645 | 193 | 20.49% | $40.73M |
$14,315,062 | 61 | -6.21% | $41.72M | |
$1,695,621 | 55 | 17.90% | $44.75M | |
$459,011,221 | 33 | 33.04% | $44.64M | |
$2,239,226 | 28 | 3.41% | $41.92M | |
$36,557,692 | 17 | 3.38% | $35.52M | |
$7,733,516 | 17 | 73.42% | $39.82M | |
$20,234,041 | 17 | 2.09% | $42.16M | |
$47,863,113 | 17 | -22.07% | $44.29M | |
$1,044,754 | 13 | -23.07% | $39.45M | |
$232,423 | 8 | 14.22% | $37.65M | |
$478,647 | 7 | 69.41% | $44.77M | |
$22,090,972 | 7 | -3.49% | $38.58M | |
$106,599,960 | 6 | -7.63% | $44.27M | |
$149,996 | 5 | 16.26% | $36.34M | |
$26,254,149 | 5 | 49.97% | $36.32M | |
$105,079 | 4 | -41.57% | $40.06M | |
$157,740 | 3 | 153.95% | $39M | |
$150,000 | 1 | 5.48% | $44.33M |
CAMP Institutional Investors: Active Positions
| Increased Positions | 36 | +600% | 12M | +2,062.73% |
| Decreased Positions | 2 | -33.33% | 49,504 | -8.25% |
| New Positions | 33 | New | 12M | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 40 | +566.67% | 13M | +2,054.47% |
CAMP Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Enavate Sciences Gp, Llc | $7,382.00 | 18.93% | 3.79M | +4M | New | 2024-12-31 |
| 5Am Venture Management, Llc | $5,709.00 | 14.64% | 2.93M | +3M | New | 2024-12-31 |
| Ah Capital Management, L.L.C. | $4,144.00 | 10.63% | 2.13M | +2M | New | 2024-12-31 |
| Harbourvest Partners Llc | $2,480.00 | 6.36% | 1.27M | +1M | New | 2024-12-31 |
| Fmr Llc | $1,472.00 | 3.78% | 755,025 | +755,025 | New | 2024-12-31 |
| Franklin Resources Inc | $1,238.00 | 3.18% | 635,000 | +635,000 | New | 2024-12-31 |
| Blackrock, Inc. | $578.00 | 1.48% | 296,216 | +30,846 | +11.62% | 2025-03-31 |
| Citadel Advisors Llc | $390.00 | 1% | 200,000 | +200,000 | New | 2024-12-31 |
| Alyeska Investment Group, L.P. | $390.00 | 1% | 200,000 | +200,000 | New | 2024-12-31 |
| Vanguard Group Inc | $366.00 | 0.94% | 187,916 | +187,916 | New | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Price to Earnings
Price/Earnings to Growth
Price to Sales
Price to Book
Price/Free Cash Flow
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.